Wis., discusses his priorities for the newly created Make America Healthy Again caucus amid the Trump administraton’s mass ...

Following a lackluster 2024, shares of major drug markers kicked off 2025 with an upbeat quarterly results reading.

Much to the Democrats’ chagrin, Robert F. Kennedy Jr. is now the United States’ new Health and Human Services secretary.

The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades, as large ...

The Arkansas General Assembly gaveled in a new legislative session last month in Little Rock and members of both the House ...

US aid freeze affects HIV and malaria supply chains, FDA postpones rare disease events, and a leap in Texas measles cases. Meanwhile, Mirum Pharma's drug gets FDA approval, Eli Lilly invests in a ...

AstraZeneca is paying $160 million for FibroGen’s China business, giving the U.K.-based Big Pharma the regional rights to ...

Billionaire Investor Mark Cuban sits down with Angelica Peebles to discuss convincing big pharma to move away from the PBMs ...

Persistently high rates of both type 1 and 2 diabetes as well as racial health disparities are indicators of lingering gaps in care for Indigenous communities.

The Make America Healthy Again movement had a negative impact on pharmaceutical innovation and the corporations responsible for it.

The discovery of this hormone paved the way for Ozempic, making the Gila monster an enormously profitable gift to modern ...

While the "Make America Healthy Again" movement has gone all-in on Trump, progress on healthy food and toxic chemicals will ...